212 related articles for article (PubMed ID: 34015290)
1. Amelioration of osteogenesis in iPSC-derived mesenchymal stem cells from osteogenesis imperfecta patients by endoplasmic reticulum stress inhibitor.
Duangchan T; Tawonsawatruk T; Angsanuntsukh C; Trachoo O; Hongeng S; Kitiyanant N; Supokawej A
Life Sci; 2021 Aug; 278():119628. PubMed ID: 34015290
[TBL] [Abstract][Full Text] [Related]
2. 4-Phenylbutyric acid enhances the mineralization of osteogenesis imperfecta iPSC-derived osteoblasts.
Takeyari S; Kubota T; Ohata Y; Fujiwara M; Kitaoka T; Taga Y; Mizuno K; Ozono K
J Biol Chem; 2021; 296():100027. PubMed ID: 33154166
[TBL] [Abstract][Full Text] [Related]
3. Galunisertib downregulates mutant type I collagen expression and promotes MSCs osteogenesis in pediatric osteogenesis imperfecta.
Infante A; Alcorta-Sevillano N; Macías I; Cabodevilla L; Medhat D; Lafaver B; Crawford TK; Phillips CL; Bueno AM; Sagastizabal B; Arroyo M; Campino A; Gerovska D; Araúzo-Bravo M; Gener B; Rodríguez CI
Biomed Pharmacother; 2024 Jun; 175():116725. PubMed ID: 38744219
[TBL] [Abstract][Full Text] [Related]
4. 4-PBA ameliorates cellular homeostasis in fibroblasts from osteogenesis imperfecta patients by enhancing autophagy and stimulating protein secretion.
Besio R; Iula G; Garibaldi N; Cipolla L; Sabbioneda S; Biggiogera M; Marini JC; Rossi A; Forlino A
Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt A):1642-1652. PubMed ID: 29432813
[TBL] [Abstract][Full Text] [Related]
5. Bone marrow mesenchymal stem cell donors with a high body mass index display elevated endoplasmic reticulum stress and are functionally impaired.
Ulum B; Teker HT; Sarikaya A; Balta G; Kuskonmaz B; Uckan-Cetinkaya D; Aerts-Kaya F
J Cell Physiol; 2018 Nov; 233(11):8429-8436. PubMed ID: 29797574
[TBL] [Abstract][Full Text] [Related]
6. Conditioned Medium Enhances Osteogenic Differentiation of Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells.
Zhong S; He X; Li Y; Lou X
Tissue Eng Regen Med; 2019 Apr; 16(2):141-150. PubMed ID: 30989041
[TBL] [Abstract][Full Text] [Related]
7. Cellular stress due to impairment of collagen prolyl hydroxylation complex is rescued by the chaperone 4-phenylbutyrate.
Besio R; Garibaldi N; Leoni L; Cipolla L; Sabbioneda S; Biggiogera M; Mottes M; Aglan M; Otaify GA; Temtamy SA; Rossi A; Forlino A
Dis Model Mech; 2019 Jun; 12(6):. PubMed ID: 31171565
[TBL] [Abstract][Full Text] [Related]
8. The synergistic effect of NELL1 and adipose-derived stem cells on promoting bone formation in osteogenesis imperfecta treatment.
Liu Y; Ju M; Wang Z; Li J; Shao C; Fu T; Jing Y; Zhao Y; Lv Z; Li G
Biomed Pharmacother; 2020 Aug; 128():110235. PubMed ID: 32454289
[TBL] [Abstract][Full Text] [Related]
9. In Vitro Modelling of Osteogenesis Imperfecta with Patient-Derived Induced Mesenchymal Stem Cells.
Claeys L; Zhytnik L; Ventura L; Wisse LE; Eekhoff EMW; Pals G; Bravenboer N; Heine VM; Micha D
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542391
[TBL] [Abstract][Full Text] [Related]
10. 4-PBA Treatment Improves Bone Phenotypes in the Aga2 Mouse Model of Osteogenesis Imperfecta.
Duran I; Zieba J; Csukasi F; Martin JH; Wachtell D; Barad M; Dawson B; Fafilek B; Jacobsen CM; Ambrose CG; Cohn DH; Krejci P; Lee BH; Krakow D
J Bone Miner Res; 2022 Apr; 37(4):675-686. PubMed ID: 34997935
[TBL] [Abstract][Full Text] [Related]
11. CRISPR/Cas9 correction of a dominant cis-double-variant in COL1A1 isolated from a patient with osteogenesis imperfecta increases the osteogenic capacity of induced pluripotent stem cells.
Cao Y; Li L; Ren X; Mao B; Yang Y; Mi H; Guan Y; Li S; Zhou S; Guan X; Yang T; Zhao X
J Bone Miner Res; 2023 May; 38(5):719-732. PubMed ID: 36734182
[TBL] [Abstract][Full Text] [Related]
12. Reiterative infusions of MSCs improve pediatric osteogenesis imperfecta eliciting a pro-osteogenic paracrine response: TERCELOI clinical trial.
Infante A; Gener B; Vázquez M; Olivares N; Arrieta A; Grau G; Llano I; Madero L; Bueno AM; Sagastizabal B; Gerovska D; Araúzo-Bravo MJ; Astigarraga I; Rodríguez CI
Clin Transl Med; 2021 Jan; 11(1):e265. PubMed ID: 33463067
[TBL] [Abstract][Full Text] [Related]
13. Impaired osteoblastogenesis in a murine model of dominant osteogenesis imperfecta: a new target for osteogenesis imperfecta pharmacological therapy.
Gioia R; Panaroni C; Besio R; Palladini G; Merlini G; Giansanti V; Scovassi IA; Villani S; Villa I; Villa A; Vezzoni P; Tenni R; Rossi A; Marini JC; Forlino A
Stem Cells; 2012 Jul; 30(7):1465-76. PubMed ID: 22511244
[TBL] [Abstract][Full Text] [Related]
14. Modification of COL1A1 in Autologous Adipose Tissue-Derived Progenitor Cells Rescues the Bone Phenotype in a Mouse Model of Osteogenesis Imperfecta.
Liu Y; Wang Z; Ju M; Zhao Y; Jing Y; Li J; Shao C; Fu T; Lv Z; Li G
J Bone Miner Res; 2021 Aug; 36(8):1521-1534. PubMed ID: 33950576
[TBL] [Abstract][Full Text] [Related]
15. Osteoblastic differentiation of bone marrow mesenchymal stromal cells in Bruck Syndrome.
Kaneto CM; Lima PS; Zanette DL; Oliveira TY; de Assis Pereira F; Lorenzi JC; Dos Santos JL; Prata KL; Neto JM; de Paula FJ; Silva WA
BMC Med Genet; 2016 May; 17(1):38. PubMed ID: 27146342
[TBL] [Abstract][Full Text] [Related]
16. Restoration of Osteogenesis by CRISPR/Cas9 Genome Editing of the Mutated
Jung H; Rim YA; Park N; Nam Y; Ju JH
J Clin Med; 2021 Jul; 10(14):. PubMed ID: 34300306
[TBL] [Abstract][Full Text] [Related]
17. Gene expression profiling of bone marrow mesenchymal stem cells from Osteogenesis Imperfecta patients during osteoblast differentiation.
Kaneto CM; Pereira Lima PS; Prata KL; Dos Santos JL; de Pina Neto JM; Panepucci RA; Noushmehr H; Covas DT; de Paula FJA; Silva WA
Eur J Med Genet; 2017 Jun; 60(6):326-334. PubMed ID: 28396251
[TBL] [Abstract][Full Text] [Related]
18. Identification of a family with van der Hoeve's syndrome harboring a novel COL1A1 mutation and generation of patient-derived iPSC lines and CRISPR/Cas9-corrected isogenic iPSCs.
Li S; Mei L; He C; Cai X; Wu H; Wu X; Liu Y; Feng Y; Song J
Hum Cell; 2024 May; 37(3):817-831. PubMed ID: 38379122
[TBL] [Abstract][Full Text] [Related]
19. Metformin induces osteoblastic differentiation of human induced pluripotent stem cell-derived mesenchymal stem cells.
Wang P; Ma T; Guo D; Hu K; Shu Y; Xu HHK; Schneider A
J Tissue Eng Regen Med; 2018 Feb; 12(2):437-446. PubMed ID: 28494141
[TBL] [Abstract][Full Text] [Related]
20. Normal collagen and bone production by gene-targeted human osteogenesis imperfecta iPSCs.
Deyle DR; Khan IF; Ren G; Wang PR; Kho J; Schwarze U; Russell DW
Mol Ther; 2012 Jan; 20(1):204-13. PubMed ID: 22031238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
